Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Lymphocytes: not useless after all.

Julie Clayton¹

¹Julie.p.clayton@blueyonder.co.uk

The Journal of Experimental Medicine

|April 11, 2006

Summary

This summary is machine-generated.

N. Avrion Mitchison discovered that lymphocytes, once considered unimportant, were capable of initiating tumor rejection in mice. This finding revolutionized immunology and cancer research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurodevelopmental copy-number variants increase risk of internalizing and cardiometabolic multimorbidity: Findings from the UK Biobank.

American journal of human genetics·2026

Same author

Developing a core outcome set for interventions in people with mild cognitive impairment: study protocol.

BMJ open·2025

Same author

Comparison of lotions, creams, gels and ointments for the treatment of childhood eczema: the BEE RCT.

Health technology assessment (Winchester, England)·2023

Same author

Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial.

The Lancet. Child & adolescent health·2022

Same author

Engaging with diverse audiences to raise awareness about childhood eczema: reflections from two community events.

Research involvement and engagement·2021

Same author

People and teams matter in organizational change: professionals' and managers' experiences of changing governance and incentives in primary care.

Health services research·2013

Same journal

Both soluble and cell surface CD137 expressed by Foxp3+ CD4 T cells restrain autoimmune diabetes.

The Journal of experimental medicine·2026

Same journal

Regulation of solid tumors by the peripheral nervous system.

The Journal of experimental medicine·2026

Same journal

Friend or foe? IFNλ drives fibrosis.

The Journal of experimental medicine·2026

Same journal

BAd-looking or CHarming: The two faces of BACH2.

The Journal of experimental medicine·2026

Same journal

Bridging veins govern discrepancy of CSF efflux into dura mater in mice.

The Journal of experimental medicine·2026

Same journal

Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation.

The Journal of experimental medicine·2026

See all related articles

Area of Science:

Immunology
Cancer Research
Cell Biology

Background:

Lymphocytes were historically underestimated in their physiological roles.
N. Avrion Mitchison's pioneering work in the mid-20th century challenged existing paradigms.
Early research focused on the adaptive immune system's potential in oncology.

Discussion:

Mitchison's experiments demonstrated a critical link between immune surveillance and tumor growth.
The study highlighted the potent anti-tumorigenic capabilities of lymphocytes.
This foundational research paved the way for understanding immune-mediated cancer therapies.

Key Insights:

Lymphocytes possess inherent tumor-rejection properties.
Immune cells play a crucial role in preventing cancer development.

Related Experiment Videos

The adaptive immune system is a key target for cancer immunotherapy.

Outlook:

Further research into lymphocyte function continues to drive advancements in cancer treatment.
Understanding these mechanisms is vital for developing novel immunotherapies.
The legacy of Mitchison's work informs contemporary cancer immunology strategies.